April 30, 2021
An efficacious treatment that reduces the symptoms and risk factors associated with obstructive hypertrophic cardiomyopathy delivers great value to patients.…
April 30, 2021
Very few of the more than 5 million Americans, or their caregivers, who live with Alzheimer’s have ever heard of the Institute for Clinical and Economic Review.
March 3, 2021
Preventing a serious cardiac event is a top priority for my patients, but the Institute for Clinical and Economic Review is about to make prevention a whole lot harder.
December 15, 2020
When you or someone you love has a cardiovascular event, life gets real – fast.
February 25, 2020
What is the value of advanced medicine for a patient living with migraine? It’s not a simple question.
December 19, 2019
Before closing the door on 2019, IfPA looks back at the trends that impacted patient access this year.
December 3, 2019
The QALY gives a one-size-fits-all measure of value that doesn’t reflect the needs and experiences of real patients.
November 12, 2019
If you don’t know ICER, you should. IfPA’s new videos explain what the health economic organization is leaving out of…
October 22, 2019
Not only is cystic fibrosis a devastating disease, most patients living with cystic fibrosis do not have access to an…
September 10, 2019
ICER recently released an updated draft of its framework. What do these changes mean for real patients who want to access innovative medicine?